| __timestamp | Cytokinetics, Incorporated | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 4167274 |
| Thursday, January 1, 2015 | 46398000 | 5247851 |
| Friday, January 1, 2016 | 59897000 | 4925118 |
| Sunday, January 1, 2017 | 90296000 | 14930297 |
| Monday, January 1, 2018 | 89135000 | 25371768 |
| Tuesday, January 1, 2019 | 86125000 | 23921274 |
| Wednesday, January 1, 2020 | 96951000 | 25338236 |
| Friday, January 1, 2021 | 159938000 | 20182966 |
| Saturday, January 1, 2022 | 240813000 | 17562000 |
| Sunday, January 1, 2023 | 330123000 | 25212000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Pharming Group N.V. and Cytokinetics, Incorporated from 2014 to 2023. Over this period, Cytokinetics has seen a staggering increase in its cost of revenue, growing by over 640%, from approximately $44 million in 2014 to $330 million in 2023. This reflects the company's aggressive expansion and investment in research and development.
Conversely, Pharming Group N.V. has maintained a more stable cost structure, with a modest increase of around 500% over the same period, peaking at $25 million in 2018. This stability suggests a more conservative growth strategy. The contrasting approaches of these companies highlight the diverse strategies within the pharmaceutical sector, offering valuable insights for potential investors.
Eli Lilly and Company vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
AstraZeneca PLC vs Cytokinetics, Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Pfizer Inc. vs Cytokinetics, Incorporated
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue Comparison: Incyte Corporation vs Cytokinetics, Incorporated
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Pharming Group N.V.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Pharming Group N.V.
Analyzing Cost of Revenue: Catalent, Inc. and Pharming Group N.V.
Comparing Cost of Revenue Efficiency: Sarepta Therapeutics, Inc. vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Cytokinetics, Incorporated vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored